| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000015460 |
| Receipt No. | R000017941 |
| Official scientific title of the study | Assessment of the incidence of surgical site infections after digestive surgery with preoperative oral antibiotics. |
| Date of disclosure of the study information | 2014/12/01 |
| Last modified on | 2016/04/17 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Assessment of the incidence of surgical site infections after digestive surgery with preoperative oral antibiotics. | |
| Title of the study (Brief title) | Assessment of the incidence of surgical site infections after digestive surgery with preoperative oral antibiotics. | |
| Region |
|
|
| Condition | ||
| Condition | Patients with lower digestive surgery (Inflammatory bowel disease, Colorectal cancer) | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the efficacy of preoperative oral antibiotics for surgical site infection in patients with lower digestive surgery |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The rate of surgical site infection at 30th days after surgery |
| Key secondary outcomes | Safety of the preoperative oral antibiotics. |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | oral antibiotics | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with IBD or colorectal cancer, who will perform digestive surgery. No allergy for Ciprofloxacin and Metronidazole. | |||
| Key exclusion criteria | Patients with allergy for Ciprofloxacin or Metronidazole. | |||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhiro Watanabe |
| Organization | Tohoku University Hospital |
| Division name | Surgery |
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi |
| TEL | +81-22-717-7205 |
| k-wata@surg1.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Kazuhiro Watanabe |
| Organization | Tohoku University Hospital |
| Division name | Surgery |
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi |
| TEL | +81-22-717-7205 |
| Homepage URL | |
| k-wata@surg1.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Dep. Surgery, Tohoku University Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | kouhi |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017941 |